anti-CD2AP antibody product blog
Tags: Antibody; Polyclonal Antibody; CD2AP; anti-CD2AP antibody;
The CD2AP n/a (Catalog #MBS415781) is an Antibody produced from Rabbit and is intended for research purposes only. The product is available for immediate purchase. The Anti-CD2AP Antibody reacts with Human, Mouse, Rat and may cross-react with other species as described in the data sheet. MyBioSource\'s CD2AP can be used in a range of immunoassay formats including, but not limited to, Peptide ELISA (EIA), Western Blot, Immunohistochemistry (IHC).Peptide ELISA titer: 1:5,000-1:10,000
Western blot analysis: 1:500-1:2,000
Immunohistochemistry: 1:100-500
Optimal dilutions/concentrations should be determined by the end user. Researchers should empirically determine the suitability of the CD2AP n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
This gene encodes a scaffolding molecule that regulates the actin cytoskeleton. The protein directly interacts with filamentous actin and a variety of cell membrane proteins through multiple actin binding sites, SH3 domains, and a proline-rich region containing binding sites for SH3 domains. The cytoplasmic protein localizes to membrane ruffles, lipid rafts, and the leading edges of cells. It is implicated in dynamic actin remodeling and membrane trafficking that occurs during receptor endocytosis and cytokinesis. Haploinsufficiency of this gene is implicated in susceptibility to glomerular disease. [provided by RefSeq, Jul 2008].
Storage Buffer: PBS, pH 7.4 with 0.02% Sodium Azide. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD2AP are readily searchable from our website. Different antibodies against the same target such as CD2AP may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.